Insider Sales at Biohaven Pharmaceutical Holding (BHVN) are Significant and Extend the Selling Trend of Last Quarter

Thursday, January 18, 2018 10:15 PM ET

Insider Sales at Biohaven Pharmaceutical Holding (BHVN) are Significant and Extend the Selling Trend of Last Quarter

There was a notable level of share sales at Biohaven Pharmaceutical Holding by insiders today, as revealed in form 4 documents filed with the SEC. Two insiders — Gregory Bailey, Director, and Dr Declan Doogan, Director — disposed of 168,058 shares in the company having a market value of approximately $4,512,097. There have been 5 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 716,423 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 884,481 shares and have averaged 126,354 shares per transaction over this time period.

The number of insider buy/sell trades at Biohaven Pharmaceutical Holding is above that of the 191 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 151 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 25,652,544 shares purchased and 11,225,091 shares sold with company insiders having bought 132,362 shares on average over this time period.

In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to evaluate and write this story.

Today’s Insider Activity
* Gregory Bailey, Director, sold 40,000 shares
* Dr Declan Doogan, Director, sold 128,058 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.